ChemoCentryx Inc

+0.22 (+1.20%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.29B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$8.6 Million
Adjusted EPS-$0.49
See more estimates
10-Day MA$16.96
50-Day MA$15.40
200-Day MA$35.62
See more pivots

ChemoCentryx Inc Stock, NASDAQ:CCXI

835 Industrial Road, Suite 600, San Carlos, California 94070
United States of America
Phone: +1.650.210.2900
Number of Employees: 133


ChemoCentryx, Inc. is a biopharmaceutical company engages in the development and commercialization of medicines. It focuses on inflammatory disorders, autoimmune diseases, and cancer. Its drug candidates such as Avacopan and CCX140, selectively blocks a specific chemoattractant receptor, leaving the rest of the immune system intact. The company was founded by Thomas J. Schall in 1997 and is headquartered in San Carlos, CA.